Samudrala Pavan Kumar, Augustine Bibin Baby, Kasala Eshvendar Reddy, Bodduluru Lakshmi Narendra, Barua Chandana, Lahkar Mangala
Department of Pharmacology and Toxicology, National Institute of Pharmaceutical Education and Research- Guwahati (NIPER Guwahati), India.
College of Veterinary Sciences (CVSc), Khanapara, India.
Pharmacognosy Res. 2015 Jan-Mar;7(1):66-73. doi: 10.4103/0974-8490.147211.
The main objective of the present study was to explore the antitumor activity of the ethyl acetate extract of the Alternanthera brasiliana (EAAB) and its antioxidant status against Ehrlich ascites carcinoma (EAC) in Swiss albino mice.
Based on the preliminary in vitro cytotoxicity studies, EAAB was selected for anti-tumor and antioxidant effects. Anticancer activity of EAAB was evaluated against EAC in Swiss albino mice at the doses of 200 and 400 mg/kg. EAAB was administered for 14 consecutive days after induction of cancer. After 24 h of the last dose and 18 h of fasting, half of the mice were sacrificed and rest were kept alive for assessing any increase in life span. The antitumor effect of EAAB was assessed by evaluating tumor volume, viable and nonviable tumor cell count, tumor weight, hematological and biochemical parameters of EAC bearing host. Furthermore, the antioxidant and histopathological parameters were evaluated.
EAAB treatment has shown significant decrease in tumor volume, viable cell count, tumor weight and elevated the life span of EAC tumor bearing mice in a dose dependent manner. In hematological profile count of RBC, hemoglobin, and WBC were found reverted to normal. EAAB also significantly decreased the levels of lipid peroxidation and significantly increased the levels of GSH, SOD and Catalase.
From the above results it may be concluded that EAAB has potent dose dependent antitumor activity and is comparable to that of 5-flourouracil.
本研究的主要目的是探讨巴西莲子草乙酸乙酯提取物(EAAB)对瑞士白化小鼠艾氏腹水癌(EAC)的抗肿瘤活性及其抗氧化状态。
基于初步的体外细胞毒性研究,选择EAAB进行抗肿瘤和抗氧化作用研究。以200和400mg/kg的剂量评估EAAB对瑞士白化小鼠EAC的抗癌活性。在诱发癌症后连续14天给予EAAB。在最后一剂给药24小时和禁食18小时后,处死一半小鼠,其余小鼠存活以评估寿命是否延长。通过评估肿瘤体积、存活和非存活肿瘤细胞计数、肿瘤重量、荷EAC宿主的血液学和生化参数来评估EAAB的抗肿瘤作用。此外,还评估了抗氧化和组织病理学参数。
EAAB治疗显示肿瘤体积、存活细胞计数、肿瘤重量显著降低,并以剂量依赖方式延长了荷EAC肿瘤小鼠的寿命。在血液学指标中,红细胞、血红蛋白和白细胞计数恢复正常。EAAB还显著降低了脂质过氧化水平,并显著提高了谷胱甘肽、超氧化物歧化酶和过氧化氢酶的水平。
从上述结果可以得出结论,EAAB具有强效的剂量依赖性抗肿瘤活性,与5-氟尿嘧啶相当。